AI Product

Kheiron Medical Technologies — Medical Imaging

Mia (Mammography Intelligent Assessment) AI breast cancer screening software supporting independent reading, concurrent reading, and triage workflows, now integrated into…

Intelligence Summary

Product
  • Active
  • Verified public sources
  • Developer Kheiron Medical Technologies
  • Category Medical Imaging
  • Status Active
  • Latest update 2016: Kheiron Medical Technologies founded in London; Peter Kecskemethy is CEO and Co-Founder.
  • Documentation Official page
  • Last reviewed Jul 2026
5 Technologies

Official product page

Target customer

National and regional breast screening programs, radiology departments, and imaging network operators seeking CE-marked AI augmentation for mammography workflows.

Features & capabilities

Industries: AI in Healthcare; Medical Imaging

Related reports

Related insights

Overview

Mia (Mammography Intelligent Assessment) AI breast cancer screening software supporting independent reading, concurrent reading, and triage workflows, now integrated into DeepHealth's SmartMammo portfolio following 2024 acquisition.

Product and company

Kheiron Medical Technologies — Medical Imaging is a verified product offering linked to the Brel Digital company profile for Kheiron Medical Technologies.

Use cases

Mia (Mammography Intelligent Assessment) AI breast cancer screening software supporting independent reading, concurrent reading, and triage workflows, now integrated into DeepHealth's SmartMammo portfolio following 2024 acquisition.

Target customer

National and regional breast screening programs, radiology departments, and imaging network operators seeking CE-marked AI augmentation for mammography workflows.

Technologies

Primary technologies assigned from the linked company profile: Deep Learning, Healthcare Analytics, Machine Learning, Medical Imaging, Predictive Analytics.

Sources and references

  • Official product / company source: https://www.kheironmed.com/12-more-breast-cancers-detected-with-potential-workload-savings-of-30-in-the-uks-first-prospective-evaluation-of-breast-screening-ai/
  • Supporting source: https://www.kheironmed.com/our-team/

Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.

Last reviewed

This product profile was last reviewed on 2026-07-14.

Correction request

If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.

Features and capabilities

  • Mia (Mammography Intelligent Assessment) AI breast cancer screening software supporting independent reading, concurrent reading, and triage workflows, now integrated into DeepHealth's SmartMammo portfolio following 2024 acquisition.

Extracted from the linked company product description already verified on Brel. No capabilities were invented.

Sources and references

This article draws on publicly available company information, official websites, filings, interviews, announcements, and other cited sources. Information may change over time.

Enquire about this product profile

Messages are delivered to contact@breldigital.com.